Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42946,237,2.00 [1.40-2.86],0.000149135979721
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",44422,335,1.50 [1.09-2.07],0.012433058351102
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43977,2327,1.56 [1.39-1.76],2.060533088398975e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,44463,716,1.70 [1.39-2.09],2.948044739077247e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43108,5936,1.46 [1.35-1.58],1.1950016838158464e-21
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43307,5402,1.41 [1.30-1.53],3.345390614766548e-16
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,44029,2047,1.32 [1.16-1.51],3.023555880719912e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,44304,148,1.62 [1.01-2.58],0.0449591981333092
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40981,1606,1.91 [1.66-2.19],8.839989264552464e-20
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,39552,1793,1.92 [1.67-2.20],1.989405435519594e-20
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,39429,422,2.13 [1.64-2.76],1.32256506780948e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,31238,3334,1.40 [1.26-1.56],6.621518326433295e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,39174,654,1.84 [1.47-2.30],7.958091894789368e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,44391,2409,1.39 [1.23-1.56],1.0982281858876617e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,44593,846,1.66 [1.37-2.00],2.019297192837933e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,43204,1554,1.62 [1.40-1.87],5.287768315837873e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,44478,1769,1.88 [1.65-2.14],6.1794001686619155e-21
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,42319,337,1.51 [1.09-2.07],0.0117990952384447
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,44683,81,1.90 [1.08-3.33],0.0255412579289382
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,44260,1551,1.91 [1.66-2.19],1.05472459517084e-19
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,44286,130,1.55 [0.93-2.59],0.0898732865910649
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,44537,269,1.74 [1.27-2.40],0.0006461307124501
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",44507,239,1.72 [1.23-2.42],0.0017130973287405
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,42347,697,1.88 [1.54-2.30],7.0532044682815e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,42114,464,1.52 [1.16-1.99],0.0021752751863044
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,42151,169,2.19 [1.52-3.14],2.4169387378381724e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,44641,94,2.37 [1.54-3.64],8.750539020066325e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,44565,268,1.10 [0.76-1.61],0.6134815389839371
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral warts,44385,88,1.23 [0.65-2.36],0.5234346997157739
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],44413,116,0.95 [0.53-1.70],0.8579606643056614
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,44173,510,0.93 [0.70-1.23],0.6007370945016668
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,44531,104,1.09 [0.60-1.99],0.7721870060168596
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,44488,109,1.15 [0.64-2.05],0.6478422754804329
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20474,108,0.83 [0.44-1.55],0.5617814766952836
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",44105,2465,1.04 [0.91-1.18],0.5819286559247087
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of meninges,44657,102,0.94 [0.50-1.74],0.8348543929452096
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,44571,121,1.02 [0.58-1.80],0.9420145202906152
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,44638,182,0.84 [0.53-1.35],0.4787702888311582
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of ovary,24100,150,1.03 [0.63-1.70],0.9013760694840252
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,44640,627,0.95 [0.74-1.23],0.7172870302590987
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Caecum,44649,508,1.12 [0.85-1.47],0.4221742714469423
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",44490,124,1.44 [0.85-2.45],0.1768351198856131
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Descending colon,44640,378,0.88 [0.63-1.22],0.4353247105242497
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,44565,604,0.91 [0.70-1.18],0.4809073889196847
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,44478,1072,1.11 [0.92-1.34],0.269133896970322
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,44631,725,1.11 [0.88-1.40],0.3609212933002259
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Carcinoma in situ of breast,19562,122,1.48 [0.89-2.47],0.1319304824664521
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19633,140,1.35 [0.82-2.22],0.231080110852306
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",35608,95,3.81 [2.79-5.20],3.1349238112554877e-17
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",35632,119,2.20 [1.39-3.50],0.0008305029060214
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",44592,206,1.29 [0.85-1.95],0.2398121710454298
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",44593,201,1.31 [0.86-2.00],0.2032598527154425
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Leiomyoma of uterus,23285,505,0.89 [0.68-1.17],0.4170536040715669
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lung cancer and mesothelioma,31034,589,1.34 [1.05-1.71],0.0201163197027592
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,35606,93,3.65 [2.63-5.08],1.2230803474806511e-14
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35837,324,1.10 [0.78-1.56],0.5736754018944767
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35854,341,1.41 [1.02-1.95],0.03753488190739
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19765,168,1.81 [1.19-2.74],0.0055482262674635
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",35655,142,2.54 [1.74-3.69],1.28471171044666e-06
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",35687,174,1.24 [0.78-1.97],0.3620092601384347
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",35688,175,1.85 [1.22-2.80],0.0034655028581812
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19727,130,1.53 [0.94-2.51],0.0869834958043074
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",35672,159,0.55 [0.33-0.91],0.0214658608428426
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17098,1182,0.95 [0.79-1.14],0.5712742130859214
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35717,204,1.19 [0.77-1.83],0.4311090686924812
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",35643,130,1.24 [0.73-2.13],0.4268376882020521
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,35691,178,1.05 [0.65-1.68],0.8462783093174074
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,44346,358,0.99 [0.71-1.38],0.9713179553490736
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of trunk,44615,156,0.92 [0.55-1.53],0.751504915492332
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanoma in situ,35570,140,0.92 [0.54-1.59],0.7766704195030073
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",35674,161,2.64 [1.88-3.72],2.2368755925979738e-08
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35790,277,2.60 [2.02-3.35],1.0535178781247132e-13
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35916,403,1.20 [0.89-1.62],0.240678237463869
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",35685,172,2.69 [1.95-3.69],1.1017741290536322e-09
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,44371,280,0.86 [0.59-1.26],0.4390684479655514
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",37351,1838,0.97 [0.83-1.12],0.6664239446584399
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",37449,1936,1.00 [0.87-1.16],0.9619917398060468
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,44168,598,1.91 [1.55-2.35],1.176881103317988e-09
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,41488,152,2.26 [1.49-3.42],0.0001298027567971
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,43697,127,1.55 [0.94-2.55],0.0877151755725529
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,43343,4903,1.37 [1.26-1.50],5.233561273669e-13
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,42223,80,1.06 [0.52-2.14],0.8801720904227869
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43972,85,2.87 [1.87-4.40],1.299453095600619e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43872,2536,1.36 [1.21-1.53],3.767501740218892e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43870,2534,1.36 [1.21-1.53],4.069996731374689e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,41484,148,2.37 [1.58-3.57],3.4298419367341623e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,44130,1987,1.52 [1.34-1.73],2.3575639026511037e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,44086,199,1.45 [0.96-2.19],0.0777531843124765
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,43678,108,2.07 [1.30-3.29],0.0021580862074154
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,43680,110,1.53 [0.89-2.65],0.126248721961799
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,44350,463,2.09 [1.65-2.64],8.660510498016248e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,44506,94,2.19 [1.39-3.45],0.0007125802256345
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",44271,384,2.10 [1.62-2.71],1.5551939014502034e-08
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,42319,176,0.85 [0.53-1.37],0.5062016985302541
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34684,519,1.66 [1.28-2.15],0.0001256329040443
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,41662,195,0.74 [0.47-1.17],0.1977820764896263
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,41686,219,1.17 [0.77-1.79],0.4526738236104503
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,34260,95,1.89 [1.06-3.38],0.0322982284663196
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,41528,108,1.45 [0.82-2.56],0.2023381163336777
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,40594,395,0.99 [0.72-1.36],0.964714642731793
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",43904,914,1.12 [0.91-1.37],0.2985827451707006
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,43453,463,0.82 [0.60-1.10],0.1841720395248636
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,43169,179,0.87 [0.54-1.41],0.5685765775868032
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,44086,2666,1.14 [1.01-1.28],0.0286302794490313
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,39026,2595,1.16 [1.03-1.31],0.0164774558724791
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",34275,110,1.46 [0.82-2.59],0.1989971858908871
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",41293,138,1.42 [0.86-2.35],0.1748715699795531
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34638,473,1.13 [0.85-1.50],0.4108911942623191
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,34270,105,1.26 [0.69-2.30],0.4518255875696356
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40211,6046,1.24 [1.14-1.34],2.05675091585279e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,34508,343,1.56 [1.13-2.16],0.0063416823220448
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,35118,953,1.27 [1.04-1.55],0.0176260331117508
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,44550,542,1.05 [0.80-1.37],0.7378119399471947
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,44225,217,0.60 [0.39-0.93],0.0223108458411655
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,34386,221,1.24 [0.81-1.88],0.3181802201069835
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",34269,104,3.36 [2.26-4.97],1.678082195776863e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,43759,2604,1.34 [1.20-1.51],7.063448680934493e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,34595,430,2.15 [1.65-2.79],1.1135014535848514e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34632,467,1.69 [1.29-2.21],0.0001466563918945
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",35253,1088,1.18 [0.98-1.43],0.0862346168143351
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,34351,186,1.61 [1.04-2.49],0.0312528958331614
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,44213,205,0.57 [0.36-0.89],0.0144992954677379
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,35194,1029,1.71 [1.43-2.04],3.468103295370031e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34995,830,1.71 [1.40-2.10],1.503970026386276e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,40312,113,1.61 [0.95-2.72],0.0754054800112264
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42717,8552,1.28 [1.20-1.37],1.7578528256510681e-13
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,41230,75,1.39 [0.70-2.75],0.3440502059885996
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,41252,97,1.06 [0.56-1.98],0.8668838179195393
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,44377,3310,1.03 [0.93-1.15],0.5755690908610871
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",44378,3305,1.03 [0.92-1.15],0.6032855182522088
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,41241,86,1.40 [0.74-2.66],0.2978994441513283
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,44089,2071,1.04 [0.91-1.19],0.5618676185754319
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36837,2672,1.63 [1.45-1.82],2.6286910015642825e-17
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,44664,362,1.60 [1.18-2.16],0.0025327045196294
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,43118,128,1.41 [0.83-2.39],0.2080374838369388
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,42204,186,1.10 [0.70-1.73],0.6872347871521309
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,42263,245,1.09 [0.74-1.63],0.6556573214586515
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",34444,279,1.64 [1.15-2.32],0.0058454808206103
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40690,267,2.05 [1.49-2.84],1.1993510135878297e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3657,142,1.59 [0.97-2.59],0.0652192588550036
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3892,422,0.96 [0.71-1.29],0.7971285610702747
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,40529,106,2.83 [1.78-4.50],1.039135501336566e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3596,82,1.76 [0.93-3.31],0.0811847713202789
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,43613,3190,1.73 [1.56-1.91],1.575300908931642e-26
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,43560,570,1.00 [0.77-1.31],0.993292216137321
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40821,622,1.33 [1.05-1.69],0.0181873380768067
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,35435,1270,1.57 [1.33-1.86],8.885319447984866e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",44485,416,1.34 [1.00-1.80],0.0477894760395371
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),42755,278,1.40 [0.98-2.00],0.0629101676102407
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,40876,2027,1.20 [1.05-1.38],0.0086200003001182
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,42889,412,1.42 [1.06-1.90],0.0182502058695839
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,42575,98,1.72 [0.99-2.98],0.0539969982254601
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",42811,334,2.07 [1.58-2.71],1.3996660290180094e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27711,3218,1.36 [1.22-1.52],4.5865908434568334e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,AV-block,37759,725,1.08 [0.86-1.37],0.4996072626336905
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",44581,704,0.94 [0.74-1.19],0.6115529511087141
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiac arrest,24816,323,2.11 [1.57-2.82],5.59012665347621e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,37330,296,1.17 [0.82-1.68],0.3908150056118097
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",37200,166,1.35 [0.85-2.15],0.2093629904305596
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,44679,78,1.31 [0.66-2.60],0.4475871697773419
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,38817,1783,1.32 [1.14-1.53],0.0002020458390097
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,42376,3559,1.34 [1.21-1.48],2.0958848043214023e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,39120,13134,1.22 [1.16-1.29],8.228184221777156e-13
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,42314,450,1.50 [1.14-1.97],0.0039753297506147
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Endocarditis,37153,119,2.11 [1.30-3.45],0.0027501494306995
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",44326,1857,1.65 [1.44-1.88],2.361223909326295e-13
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,40688,11240,1.19 [1.12-1.26],4.090887572973395e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",40700,11252,1.19 [1.12-1.26],9.991276015425871e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",44380,133,4.30 [3.39-5.44],1.0997701175319596e-33
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29775,327,2.57 [2.00-3.30],1.10439807882048e-13
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29620,172,2.08 [1.40-3.10],0.0002950842445514
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,44438,1946,1.26 [1.10-1.44],0.0011425659624595
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,43122,181,1.04 [0.65-1.66],0.8672518616605454
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",42682,3833,1.29 [1.17-1.42],5.013675058678819e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",44054,953,1.30 [1.07-1.59],0.0081551869734078
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,37651,617,1.52 [1.19-1.93],0.0006499150233589
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43893,1443,1.33 [1.14-1.56],0.0003692258628348
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",40065,1216,1.43 [1.20-1.70],4.388740289863989e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",44522,273,1.29 [0.90-1.86],0.1701444212640521
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",44631,532,1.42 [1.10-1.84],0.00717773067544
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Oesophageal varices,41954,90,4.79 [3.64-6.30],3.355639750914965e-29
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other aneurysm,42605,128,0.88 [0.50-1.54],0.655112479111233
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,37765,731,1.31 [1.05-1.65],0.0189459555020385
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,42649,172,1.50 [0.97-2.32],0.0652577332393857
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42884,407,1.81 [1.39-2.36],1.0382170937366258e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,37340,306,1.36 [0.96-1.92],0.0803577327548076
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other disorders of veins,42016,152,1.43 [0.89-2.30],0.1411006600812119
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41948,84,1.59 [0.88-2.88],0.1273447705737334
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,42267,110,1.17 [0.64-2.12],0.6092548627532761
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,42090,226,1.71 [1.18-2.48],0.004642362925842
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,38767,1733,1.48 [1.28-1.71],7.59860343676839e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,42585,93,3.55 [2.64-4.78],6.338526249594425e-17
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,43398,921,1.40 [1.16-1.70],0.0006087524887135
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,43611,608,2.05 [1.65-2.54],5.1423557207380416e-11
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",43177,1020,1.07 [0.88-1.31],0.4776407819692154
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,25057,564,1.54 [1.20-1.99],0.0007626420098178
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,43104,681,1.56 [1.25-1.95],7.111249025593373e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),42449,585,1.37 [1.07-1.75],0.0120625253234362
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43815,812,1.22 [0.99-1.52],0.0655551301985186
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,44555,1105,1.74 [1.47-2.06],1.5701083798263186e-10
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,37622,588,1.53 [1.19-1.95],0.0008251106993504
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,43603,600,2.07 [1.67-2.57],2.5694732796434053e-11
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,42478,321,1.82 [1.34-2.47],0.0001312041991349
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",44032,1091,1.25 [1.04-1.51],0.0170595565292636
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43997,1156,1.24 [1.03-1.48],0.0199468780221924
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,43076,100,1.02 [0.55-1.89],0.9588727598859648
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,42611,135,1.59 [0.97-2.60],0.0660354534804419
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,43489,388,0.91 [0.66-1.26],0.5803306389562286
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42891,441,1.34 [1.01-1.78],0.045145690729917
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,42572,708,1.40 [1.12-1.76],0.0029787267697118
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,42502,145,1.46 [0.91-2.35],0.115809097068591
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,44282,1273,1.25 [1.05-1.48],0.0102076743590702
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",44466,622,0.96 [0.75-1.24],0.7777743390928231
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",39161,2448,1.06 [0.93-1.20],0.3742981873591997
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,43559,6846,1.06 [0.98-1.14],0.1206124557254521
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",44386,727,0.93 [0.74-1.18],0.5518495519294557
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",39430,2717,1.16 [1.04-1.31],0.0108754464552023
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36855,142,0.91 [0.53-1.54],0.7207828864315845
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,43759,2365,1.15 [1.02-1.30],0.0223092247320982
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",39522,2809,1.09 [0.97-1.22],0.1577445840237391
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Vascular dementia,43863,217,1.18 [0.78-1.80],0.4316149439133444
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Alzheimer disease,44681,576,0.85 [0.65-1.11],0.2408530054821259
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",30313,103,0.73 [0.38-1.40],0.3397086223666838
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Bell's palsy,41629,139,1.79 [1.14-2.83],0.0122142496046438
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,42345,855,0.73 [0.59-0.91],0.0054633066163295
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral cysts,43990,389,1.49 [1.12-1.99],0.0067582978388432
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,44541,528,1.24 [0.95-1.61],0.1104003608595817
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,43842,94,1.32 [0.71-2.47],0.3780927642443414
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,44654,112,1.40 [0.80-2.46],0.2405434291370599
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",43723,122,1.59 [0.95-2.68],0.0793535914337995
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,42028,484,1.20 [0.91-1.59],0.2062926562698622
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43860,2316,1.14 [1.01-1.30],0.0405871486728425
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,44605,715,0.95 [0.75-1.20],0.660660973714283
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,43665,4362,1.10 [1.00-1.21],0.0502647314227834
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Generalized epilepsy,44037,93,2.03 [1.17-3.54],0.0119728939295944
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,44429,416,1.40 [1.05-1.87],0.0221414861520755
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hydrocephalus,43703,102,0.77 [0.41-1.44],0.4106701684921962
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,44647,118,1.64 [0.99-2.72],0.0561644807375133
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,41623,133,1.18 [0.70-1.99],0.526357523003776
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,41625,135,0.84 [0.49-1.45],0.5377726540430319
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Memory loss,43611,198,1.01 [0.64-1.57],0.9797434769967994
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,42156,612,1.18 [0.92-1.52],0.1800790088166875
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",44559,555,1.25 [0.97-1.61],0.0803225907610265
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Motor neuron disease,30505,258,0.80 [0.53-1.20],0.2747080957803638
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,44376,183,0.91 [0.57-1.43],0.6722840670494503
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",43538,2048,0.97 [0.84-1.11],0.6317209301889706
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,42124,6270,1.02 [0.94-1.10],0.6419291981180575
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,44061,313,1.31 [0.93-1.84],0.1261503169759831
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",42174,684,0.93 [0.74-1.19],0.5811539847389671
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",44549,494,1.85 [1.44-2.38],1.4076673732812166e-06
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35763,1101,1.00 [0.83-1.22],0.9597159571832234
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,43724,123,1.08 [0.62-1.88],0.7939301452756619
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,43840,239,0.78 [0.51-1.17],0.2274671171675157
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,44146,256,0.94 [0.63-1.39],0.7523791111876544
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,41654,164,1.73 [1.13-2.64],0.0108766324440859
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other headache syndromes,41646,102,1.30 [0.72-2.37],0.386998572330735
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,44479,878,1.05 [0.85-1.30],0.6291777762250006
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,42489,945,1.17 [0.96-1.43],0.122072233793893
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Parkinson's disease,44637,419,0.98 [0.72-1.33],0.8805354210052899
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,43696,95,1.25 [0.69-2.28],0.4575855925261334
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Restless leg syndrome,44679,113,0.90 [0.50-1.63],0.7251626371431121
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,44274,817,1.24 [1.00-1.53],0.0501999564608234
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,44138,83,2.94 [1.91-4.54],9.839945075192396e-07
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,44654,304,0.78 [0.54-1.13],0.1943118445609146
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,41581,91,1.17 [0.61-2.22],0.6370886929703379
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,44681,582,0.85 [0.65-1.11],0.2344728869654273
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),43795,210,1.18 [0.77-1.81],0.4419763837970164
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,43709,167,1.28 [0.80-2.05],0.300471833101286
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43981,678,1.13 [0.89-1.43],0.315479571397994
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,44400,396,1.40 [1.04-1.89],0.0267860907922028
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42945,92,0.37 [0.19-0.73],0.0041979561334926
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42957,104,1.09 [0.60-2.00],0.769928285583268
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",44493,91,1.72 [0.96-3.08],0.0690458463812117
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,44242,252,0.95 [0.63-1.41],0.7871547962826888
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3602,87,1.75 [0.95-3.25],0.0738022960881865
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4362,164,1.55 [0.98-2.45],0.0622205457768742
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,43709,167,1.04 [0.64-1.69],0.8585700383943669
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,44340,1781,1.19 [1.03-1.37],0.0213316244668459
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",44035,1182,1.10 [0.91-1.31],0.3199688127973027
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,43233,380,1.20 [0.87-1.64],0.2667728688399281
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",44543,1240,1.16 [0.98-1.39],0.0901794170913804
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,44667,120,0.73 [0.41-1.31],0.2945351826401989
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,44419,1116,1.11 [0.92-1.34],0.2755014610443953
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",44610,620,1.15 [0.89-1.47],0.2835739859050952
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,44521,316,1.35 [0.97-1.89],0.078171703231427
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42956,103,1.43 [0.80-2.57],0.2317190480777862
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42967,114,0.76 [0.41-1.39],0.3675799951366905
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42948,95,0.88 [0.46-1.69],0.6966247306769675
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,44521,1213,1.04 [0.87-1.25],0.6676801710966866
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,43631,323,0.69 [0.48-0.99],0.0465150747016445
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,43385,82,1.12 [0.56-2.22],0.74616333050772
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,44159,169,1.52 [0.97-2.38],0.0660074257705731
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,44454,464,1.03 [0.77-1.38],0.82458993321505
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,43637,334,1.09 [0.77-1.53],0.6300189476646758
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,44394,189,1.36 [0.88-2.10],0.166465507871894
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,44096,788,1.26 [1.02-1.57],0.0354166339137322
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,43779,237,1.08 [0.72-1.61],0.7171900127000654
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41946,3755,1.08 [0.97-1.19],0.1591104536373324
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,44397,407,1.06 [0.77-1.44],0.7313526325259117
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,44643,263,1.05 [0.72-1.54],0.7974767568023304
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,43553,700,1.08 [0.85-1.36],0.5373728666833244
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,44106,116,1.23 [0.70-2.18],0.4690340497868941
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,44643,96,0.56 [0.29-1.08],0.082239054861903
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42999,146,0.91 [0.54-1.54],0.7287267659075046
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,43109,256,0.90 [0.61-1.35],0.6211577645917399
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,42759,200,1.20 [0.78-1.86],0.4062796406605693
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,43402,99,1.57 [0.89-2.75],0.1186614843962332
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",42674,115,0.82 [0.45-1.50],0.5243544721704089
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,43458,150,0.70 [0.41-1.18],0.1808000254110021
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",43639,331,0.99 [0.70-1.40],0.9536591915164612
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,43061,208,1.35 [0.89-2.05],0.1583326672819129
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,42746,187,1.33 [0.85-2.06],0.2094730504712508
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,42698,139,1.12 [0.66-1.90],0.6707173665555004
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,41262,3071,1.12 [1.00-1.25],0.0568858274883089
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42980,127,0.94 [0.54-1.65],0.8392559349195378
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,44244,702,1.10 [0.87-1.39],0.4193002579177426
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,43641,99,1.45 [0.80-2.61],0.2163024274394412
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),43820,278,1.57 [1.11-2.21],0.0100662543726721
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,44295,152,0.94 [0.56-1.57],0.8107598724369465
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,44603,202,0.82 [0.52-1.28],0.3771885733970157
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,44456,228,1.21 [0.81-1.80],0.3433496052791729
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,44253,110,1.15 [0.64-2.07],0.6422020095094755
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,44257,114,0.68 [0.37-1.24],0.2047129212016832
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,44500,1512,1.07 [0.91-1.26],0.4185054510436123
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,44068,1080,1.16 [0.96-1.40],0.1303177807695263
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,43204,216,0.67 [0.43-1.04],0.07495225973169
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,43134,146,1.00 [0.60-1.68],0.9971613687352592
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute pharyngitis,44247,122,0.96 [0.55-1.68],0.8890909722970566
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,44495,370,1.19 [0.87-1.63],0.2662868180150791
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,44236,111,1.31 [0.75-2.30],0.3393859843117472
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza,41270,200,2.05 [1.39-3.01],0.0002715648055986
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),41266,196,2.12 [1.45-3.11],0.0001178822447542
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),30651,206,1.13 [0.73-1.75],0.5835800428658363
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic rhinitis,44467,487,0.93 [0.70-1.23],0.597892861302362
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",33071,3084,1.16 [1.04-1.30],0.008971070393439
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",33479,3034,1.15 [1.03-1.29],0.0156605647326507
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43983,238,1.95 [1.42-2.69],4.4536111600594985e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",41206,136,1.73 [1.06-2.83],0.0296251941309993
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bronchiectasis,38687,600,1.74 [1.38-2.18],1.8189632307705369e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",38183,96,1.08 [0.57-2.04],0.803674118912132
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42927,4840,1.19 [1.09-1.29],0.0001315303698152
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",42302,128,1.24 [0.72-2.11],0.4347203601326029
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,42436,262,1.07 [0.73-1.57],0.7318650567416152
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",44342,2037,1.26 [1.11-1.44],0.0005903331554289
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,42368,194,1.01 [0.65-1.59],0.9520515831611068
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41095,9043,1.23 [1.15-1.31],7.239785040622851e-10
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42816,642,1.15 [0.91-1.47],0.2404568901285936
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,42868,563,1.40 [1.18-1.67],0.0001119329005939
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Emphysema,38634,547,1.47 [1.15-1.87],0.0017748520541931
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,42380,510,1.42 [1.09-1.84],0.0095771896183833
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,44289,3219,1.61 [1.45-1.78],1.0373498355863838e-19
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,42437,567,1.51 [1.18-1.93],0.0010079295936539
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Later onset COPD,42916,1474,1.17 [1.00-1.38],0.0563942478239664
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,44658,531,1.38 [1.06-1.79],0.0162183555838471
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,42362,188,0.77 [0.48-1.23],0.2802826138386191
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,44243,1653,1.54 [1.34-1.78],3.065010982257862e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,44271,3418,1.56 [1.41-1.72],1.2353669157469145e-18
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,43628,1454,1.00 [0.85-1.18],0.9814185961000164
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,40941,88,2.94 [2.01-4.29],2.3204560855324867e-08
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,44510,704,1.78 [1.44-2.19],1.06608575844025e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,44492,2236,1.49 [1.32-1.68],2.43317345138832e-10
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,42531,1678,1.87 [1.64-2.14],1.7535575746823906e-20
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural plaque,41128,275,1.69 [1.19-2.41],0.0035397841059428
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",43856,2786,1.60 [1.44-1.79],3.4072937890852875e-17
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,44541,414,1.48 [1.11-1.98],0.0076001845329035
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumothorax,41062,209,1.48 [0.99-2.23],0.0583596890502955
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pollen allergy,44643,416,1.04 [0.77-1.41],0.8096259877932583
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,43919,113,3.33 [2.36-4.71],9.320642966011424e-12
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,30540,95,0.88 [0.45-1.70],0.7007922163183173
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,44207,1617,1.56 [1.35-1.80],1.788255353060065e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,42662,488,0.93 [0.70-1.24],0.6120683104064757
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Viral pneumonia,41484,414,1.52 [1.13-2.03],0.0053678507346751
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",44010,341,1.45 [1.05-2.00],0.0228716693681127
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20630,190,1.24 [0.78-1.96],0.362241057514588
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31679,110,1.17 [0.65-2.10],0.5967385864028844
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,44401,248,1.11 [0.75-1.64],0.6143246833883955
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute gastritis,33698,148,1.28 [0.78-2.11],0.3260759720441603
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,41516,320,1.34 [0.96-1.88],0.0902673081886079
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute peritonitis,43860,154,1.88 [1.24-2.85],0.0030172686774022
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,43149,128,1.06 [0.60-1.87],0.8378438046941574
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Barrett oesophagus,34303,753,1.07 [0.85-1.34],0.5762749373316756
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",41370,174,2.33 [1.59-3.42],1.5179220481710664e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43958,174,2.23 [1.53-3.26],3.522354477741021e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,41538,342,1.21 [0.87-1.69],0.253076799007033
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,42933,1737,1.41 [1.22-1.62],1.8485323185821813e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,34069,519,1.36 [1.05-1.76],0.0199151148128635
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,41278,82,2.51 [1.63-3.86],3.009680924818526e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",44431,184,4.13 [3.38-5.04],5.737634869454899e-44
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,41919,204,2.21 [1.62-3.03],6.281545446247138e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Collagenous colitis,41769,137,1.45 [0.88-2.37],0.1412299565487424
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,44407,330,1.15 [0.82-1.60],0.4266063391258717
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,44239,2805,1.11 [0.99-1.25],0.0818676574194443
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,41785,153,1.79 [1.17-2.72],0.0071620909461016
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",44065,110,1.87 [1.14-3.06],0.0135215576878018
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41774,142,1.94 [1.30-2.91],0.0012368141755695
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,43400,395,1.07 [0.79-1.46],0.6529891465874137
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,40119,3814,1.07 [0.97-1.19],0.181545038900136
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,44464,311,1.02 [0.72-1.45],0.9100766614830756
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,44475,1454,2.07 [1.81-2.35],5.6689125164671685e-28
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40933,7383,1.07 [0.99-1.15],0.0882053666297629
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43953,948,1.15 [0.94-1.40],0.1662348419145715
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,44528,822,1.25 [1.01-1.54],0.0403555178256927
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,43201,196,1.17 [0.76-1.80],0.4623795242575901
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,42953,108,1.27 [0.72-2.25],0.4061279256120629
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,44151,2436,1.33 [1.18-1.50],4.729011044721992e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of tongue,42969,188,1.08 [0.69-1.70],0.7374561149483653
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",43630,2434,1.44 [1.28-1.63],1.1865613682863506e-09
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36997,5428,0.94 [0.86-1.02],0.1507835660891562
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,33888,338,1.41 [1.02-1.95],0.0354557441939202
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",44526,268,1.46 [1.02-2.08],0.0387725325159284
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,44532,91,0.73 [0.37-1.42],0.3525841170024015
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,43242,221,3.88 [3.21-4.70],8.106635984797589e-44
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31825,256,1.11 [0.76-1.64],0.5839544277117263
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,34493,943,0.97 [0.79-1.19],0.7939640920658998
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,34170,620,1.23 [0.97-1.57],0.0926322539506995
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37844,4294,1.04 [0.94-1.14],0.4404444561275602
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,34471,921,1.23 [1.01-1.50],0.0439184141144359
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34606,14254,1.09 [1.04-1.15],0.0011108808938249
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,43695,1980,1.22 [1.07-1.40],0.0041703083847185
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,43111,106,1.54 [0.89-2.66],0.1186748833437436
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,33221,2144,0.96 [0.84-1.11],0.6017122982686043
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",43126,105,3.18 [2.28-4.42],6.966763414896587e-12
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,41859,5554,1.04 [0.96-1.13],0.3265992950949994
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,44544,86,0.80 [0.40-1.58],0.5162390369597052
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impaction of intestines,31667,98,1.30 [0.71-2.39],0.4021260481864045
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,37853,1548,1.01 [0.86-1.19],0.9207530810766638
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",36478,173,0.65 [0.39-1.07],0.0884057220921215
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31731,162,0.83 [0.50-1.37],0.4622071592444309
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41957,242,1.93 [1.40-2.65],5.239984911574462e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,32524,955,0.96 [0.79-1.18],0.7238770155047212
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,44635,623,1.94 [1.59-2.39],1.8679280632621903e-10
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42936,1304,1.41 [1.20-1.66],2.9228961308072985e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,43362,1730,1.35 [1.17-1.56],3.2250360794336205e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33866,316,1.43 [1.02-2.00],0.0362498401343043
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,34595,1045,1.20 [0.99-1.45],0.0621603097444225
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,44591,236,1.40 [0.96-2.03],0.083520937297117
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,36419,114,0.83 [0.46-1.52],0.5561979445717788
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33915,2346,1.06 [0.94-1.21],0.3405538167243536
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41675,479,1.45 [1.11-1.91],0.0067857338395883
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,41463,267,1.19 [0.82-1.73],0.358407103334096
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,34586,3017,1.10 [0.99-1.24],0.0847002996015017
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,41217,9648,1.05 [0.98-1.12],0.1559542854153644
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42938,360,1.46 [1.08-1.97],0.0152426766212698
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,44206,1185,2.14 [1.86-2.46],4.624564955815671e-26
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34700,1150,1.21 [1.01-1.46],0.0368786124860171
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,41451,255,1.50 [1.04-2.17],0.0312077526170056
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,44415,709,1.16 [0.93-1.46],0.1960922062807168
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,35172,1622,1.44 [1.25-1.67],9.598411253080412e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,43721,2006,1.24 [1.08-1.42],0.0019412949463889
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,43307,302,1.43 [1.03-1.99],0.0322596677955771
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,34458,2889,1.12 [1.00-1.26],0.0476945835408455
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36990,3440,1.18 [1.06-1.31],0.0021606674461169
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,43191,170,3.03 [2.32-3.95],3.74430181730881e-16
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,43153,1521,1.39 [1.20-1.62],1.8601307083531564e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",32161,592,1.26 [0.98-1.61],0.0734600135663544
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,44513,107,0.75 [0.40-1.38],0.3503978616489834
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,32412,843,1.24 [1.00-1.52],0.0473487844872036
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41984,269,1.64 [1.17-2.30],0.0037920887651918
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,44661,101,2.00 [1.22-3.30],0.0063360504507466
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,43013,204,1.63 [1.12-2.39],0.0115845577646234
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Toxic colitis,41727,95,1.91 [1.10-3.32],0.0216132002851778
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,34025,475,1.08 [0.81-1.44],0.6025737365816939
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,41909,277,1.44 [1.02-2.04],0.0401896478358921
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41863,231,1.48 [1.02-2.16],0.0386883345471888
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,36774,469,0.87 [0.65-1.16],0.3422104810911278
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31874,305,1.18 [0.83-1.67],0.3525661391905589
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,36747,442,1.48 [1.12-1.95],0.0058789402589398
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Volvulus,31706,137,1.09 [0.64-1.84],0.7618007344152127
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,44549,492,1.01 [0.76-1.35],0.9333103551171746
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,44129,137,1.88 [1.22-2.91],0.0044715872020449
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,41203,278,1.18 [0.82-1.70],0.3796211455484987
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,43570,1199,1.56 [1.32-1.85],2.366770396630644e-07
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",42679,308,1.30 [0.93-1.82],0.1237975739581642
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,41583,658,1.43 [1.13-1.80],0.0029168991562193
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,44148,479,1.25 [0.95-1.64],0.1136960511164845
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,44495,826,1.31 [1.06-1.61],0.0106641827729056
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,43754,85,1.69 [0.93-3.06],0.086044226557969
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41993,5486,1.14 [1.05-1.24],0.0020836496002261
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43891,761,1.01 [0.81-1.27],0.9114862007896924
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,43661,531,1.05 [0.80-1.37],0.725396913312061
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43994,1623,1.44 [1.24-1.66],1.1133754937853428e-06
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",44652,93,1.23 [0.66-2.31],0.5138615294470239
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,41035,110,2.04 [1.37-3.05],0.0004689805858757
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,43223,93,1.12 [0.59-2.13],0.7249241136160531
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,44130,461,1.25 [0.95-1.66],0.1142580308501968
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41708,783,1.10 [0.88-1.38],0.3997693764421817
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,41038,113,0.92 [0.50-1.67],0.7726823804437267
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,44531,140,1.40 [0.85-2.30],0.1885817989711705
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,42674,303,1.62 [1.16-2.26],0.0050135607983507
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,44326,334,1.28 [0.92-1.78],0.1366407781523241
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,43769,100,1.00 [0.53-1.89],0.9915032753893932
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,41037,112,0.60 [0.32-1.11],0.1029545851277533
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,43694,2769,1.17 [1.04-1.32],0.0073345237102893
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41774,849,1.12 [0.90-1.38],0.3083227542985375
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,41044,119,0.91 [0.51-1.64],0.7630032959810564
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,44529,537,1.20 [0.92-1.55],0.1816531559750386
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,43789,120,1.85 [1.16-2.96],0.0096398891849045
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,44433,441,1.27 [0.96-1.69],0.097672884462547
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,44593,536,1.02 [0.78-1.34],0.8800196302249916
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,41145,220,1.20 [0.80-1.81],0.3773856958722497
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,41383,458,0.78 [0.58-1.06],0.1129100090451593
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,44575,518,1.02 [0.77-1.34],0.9097557029265118
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",41312,387,2.07 [1.59-2.69],7.39754057877998e-08
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,44625,234,1.35 [0.91-1.99],0.1319629958344758
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,38319,188,1.11 [0.71-1.73],0.6414474949979242
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40653,9708,1.04 [0.97-1.10],0.2697972569374653
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38232,7287,1.00 [0.92-1.07],0.9161369877996796
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,38262,131,1.09 [0.64-1.87],0.7474674496858114
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38791,254,0.72 [0.48-1.07],0.1049131974141687
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38841,304,1.02 [0.71-1.46],0.9173111932894056
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,44249,158,1.25 [0.78-1.99],0.3615203067749742
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",38706,169,0.64 [0.39-1.06],0.0856120526015895
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32903,1958,0.99 [0.86-1.15],0.920524013605538
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",44437,328,1.01 [0.72-1.43],0.9445562845947691
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,39274,737,0.88 [0.70-1.12],0.2962962178750562
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37751,12512,1.03 [0.97-1.09],0.3543589858557265
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,41256,207,1.19 [0.78-1.82],0.4215681075775892
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,38394,263,1.18 [0.81-1.71],0.400662743373102
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,39131,1000,0.95 [0.78-1.15],0.586440200919593
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,43064,4527,0.98 [0.89-1.07],0.6197491130426197
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38610,479,0.96 [0.72-1.28],0.7806092848168773
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,38521,390,0.88 [0.64-1.21],0.430215181211163
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,38373,242,0.76 [0.51-1.16],0.2026865913433029
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,43529,123,1.15 [0.66-2.01],0.6248973648928872
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33850,2905,0.93 [0.82-1.05],0.2249365466997868
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31948,1003,1.36 [1.12-1.65],0.0022769702837675
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",44548,987,1.33 [1.09-1.61],0.0042795903814158
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,31074,129,0.47 [0.26-0.84],0.0100994220332669
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31529,584,0.74 [0.57-0.97],0.0286582538396507
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38651,520,1.12 [0.86-1.47],0.3945888393229816
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,32048,1103,0.99 [0.82-1.20],0.9213193534248544
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,38630,93,1.74 [0.99-3.06],0.0546604808046934
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,39608,1071,1.09 [0.90-1.31],0.3777980972194799
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,39048,511,0.84 [0.63-1.11],0.2194353636654073
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31971,1026,0.93 [0.76-1.13],0.4562072187559892
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,38263,132,1.01 [0.59-1.73],0.983713358491528
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",38233,102,1.63 [0.97-2.75],0.066710717589833
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,41171,122,2.02 [1.28-3.21],0.0026688474192281
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,44012,2963,1.18 [1.06-1.32],0.0037670602001841
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42994,1945,1.14 [0.99-1.31],0.0664790647243609
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",44429,777,1.38 [1.12-1.70],0.0027240706541961
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35246,4301,1.10 [1.00-1.21],0.0532108716308914
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,31052,107,0.58 [0.31-1.09],0.0907850506999847
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,38289,158,1.09 [0.66-1.78],0.7422410093723759
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,31036,91,1.69 [0.91-3.15],0.0984121627336004
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),31165,220,0.85 [0.55-1.31],0.4647713697593291
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,41470,421,0.97 [0.71-1.31],0.8332655946198197
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,41689,640,1.22 [0.95-1.55],0.1131624872686282
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,44628,169,1.55 [1.00-2.39],0.0499256403938311
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",41602,3065,0.99 [0.89-1.11],0.9099112324060185
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,38301,170,0.77 [0.47-1.26],0.2997542382776995
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),31189,244,0.79 [0.52-1.19],0.2554296884506816
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,39769,1232,1.00 [0.84-1.20],0.9813516667788869
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,34657,3712,0.94 [0.85-1.05],0.2574444125075281
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,43567,161,1.44 [0.91-2.29],0.12259208471754
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,44649,130,1.70 [1.06-2.71],0.0273190116234554
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,38267,136,1.01 [0.59-1.73],0.9626906848102889
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",40262,2131,1.22 [1.07-1.39],0.0024207492885916
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,38283,152,1.39 [0.86-2.24],0.1776343080837013
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33745,2800,1.02 [0.91-1.15],0.7026233614156454
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,41251,202,0.64 [0.41-1.01],0.0573790891804844
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,38219,88,0.95 [0.49-1.86],0.8867336337516981
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38809,272,0.77 [0.52-1.13],0.1810541950771998
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,39061,930,1.55 [1.28-1.87],5.699719675107506e-06
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,44028,622,1.49 [1.18-1.89],0.0008963180180905
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,39513,976,1.26 [1.04-1.53],0.0176934996681081
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,44449,757,1.44 [1.17-1.78],0.0006275260072161
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,44643,92,1.63 [0.92-2.89],0.0937138406541467
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,38460,329,1.14 [0.81-1.60],0.4531480264329447
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,35376,1289,1.10 [0.92-1.31],0.2847839681463727
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,39120,989,1.07 [0.88-1.30],0.5053497448841556
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],38530,399,0.96 [0.70-1.32],0.8039173009667446
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",31044,99,0.90 [0.47-1.71],0.7372854837306908
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35217,4272,1.14 [1.04-1.26],0.0060606393435253
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,32062,1117,0.97 [0.80-1.18],0.7627796966242291
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,43806,400,0.89 [0.65-1.22],0.4724746702332935
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",44567,108,1.70 [1.01-2.88],0.0474205851719897
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40950,85,0.63 [0.32-1.26],0.1946735115305118
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,31078,133,1.77 [1.12-2.79],0.0147221609287424
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,38714,177,0.95 [0.59-1.52],0.8325202218914274
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31733,788,1.40 [1.13-1.73],0.0019690042713103
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38665,534,0.95 [0.72-1.24],0.6861204836160063
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38974,437,0.77 [0.56-1.04],0.088643684888038
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38851,314,0.87 [0.61-1.25],0.4629686437258389
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34944,101,1.34 [0.74-2.42],0.3399158907875146
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",44650,99,1.66 [0.96-2.86],0.0696721477085986
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,39143,1012,1.02 [0.84-1.24],0.8430546336926733
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],43572,166,2.65 [2.03-3.45],4.847949375186556e-13
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,42574,4443,1.09 [0.99-1.19],0.0706504675085715
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",38360,229,0.89 [0.59-1.35],0.5869376282100229
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,39443,906,1.03 [0.84-1.27],0.7674032756539837
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,42207,400,0.89 [0.65-1.22],0.4573721827902668
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38871,334,0.78 [0.55-1.11],0.1628399233424119
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,41165,2628,0.95 [0.84-1.07],0.3701324880704093
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,40254,1717,0.89 [0.77-1.04],0.1465593347280634
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],38220,89,0.84 [0.43-1.64],0.6062188662952519
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,43658,252,2.50 [2.04-3.07],1.644628445076129e-18
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,38420,289,0.98 [0.68-1.42],0.932231409408698
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,38266,135,1.40 [0.84-2.33],0.1950897132923801
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),31042,97,0.99 [0.52-1.89],0.9747615537835116
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,43065,2587,1.81 [1.62-2.02],3.4527678273427823e-26
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18086,88,0.82 [0.42-1.61],0.5660171949615294
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23557,99,1.03 [0.56-1.90],0.9161618319132364
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,44140,541,1.23 [0.95-1.60],0.1153127363238391
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,43744,145,0.98 [0.58-1.66],0.9399272078335348
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,42807,2329,1.62 [1.43-1.83],8.176815040754271e-15
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,44333,107,2.31 [1.42-3.76],0.0007154115764541
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,44298,502,1.69 [1.31-2.18],4.743155165440344e-05
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,39449,400,1.30 [0.96-1.77],0.0846268809168362
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dialysis,40592,114,1.89 [1.13-3.17],0.0159794567322587
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19432,2837,1.00 [0.89-1.13],0.9797482408204552
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23745,287,1.13 [0.79-1.61],0.497370330203293
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Endometriosis,18150,152,1.14 [0.70-1.84],0.6034721022237965
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18342,344,0.74 [0.53-1.04],0.0820735939960655
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18877,879,0.79 [0.64-0.98],0.0302527636160071
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,37334,9109,1.09 [1.02-1.16],0.014607087071112
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,44353,127,2.55 [1.74-3.72],1.3781086830955972e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydrocele,16770,175,0.70 [0.42-1.14],0.152371770785284
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,40422,475,1.23 [0.92-1.63],0.1596638761391221
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18824,2229,1.02 [0.89-1.17],0.7376050668748904
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23683,352,1.36 [1.00-1.85],0.0478275925525081
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16794,199,0.81 [0.51-1.28],0.366126990727477
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Irregular menses,23757,111,0.57 [0.32-1.02],0.0584176750827978
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18267,269,0.93 [0.64-1.35],0.7162285403865807
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,39178,129,1.03 [0.59-1.78],0.924028523123583
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20140,2142,0.85 [0.74-0.97],0.0191891851314407
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16694,99,1.07 [0.57-2.03],0.8280815036695373
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18117,119,0.84 [0.47-1.50],0.5565249327939294
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",44665,111,1.33 [0.75-2.35],0.322902940193175
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",44666,117,1.32 [0.76-2.30],0.3200906886717102
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42877,3828,1.16 [1.05-1.28],0.0045851418774129
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,40285,1236,0.98 [0.82-1.18],0.8527130528002792
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23560,102,1.06 [0.58-1.93],0.8565134541699632
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,44571,775,1.63 [1.32-2.00],3.851962959439409e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16860,265,1.19 [0.81-1.75],0.3639008830501939
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16838,243,0.94 [0.62-1.42],0.7664203900748744
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16789,194,0.63 [0.39-1.00],0.0522196368589774
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,44616,118,0.74 [0.41-1.34],0.319026289211477
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41973,2924,1.26 [1.13-1.41],5.520716409806409e-05
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23513,182,1.57 [1.05-2.34],0.0294612766273069
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18135,137,0.83 [0.49-1.43],0.5116257416134439
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18340,342,0.80 [0.57-1.13],0.2037686382633145
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18101,103,0.80 [0.43-1.49],0.4801278488854659
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18180,182,0.64 [0.40-1.03],0.0674900597149733
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,40504,557,1.24 [0.95-1.61],0.1104164455912208
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,44052,256,1.37 [0.94-2.00],0.0981783433544689
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18266,268,1.13 [0.78-1.64],0.5222975217597314
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18089,91,0.77 [0.40-1.49],0.4382585231006641
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18561,563,0.79 [0.61-1.03],0.0842701052217086
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18139,141,0.88 [0.51-1.50],0.6400187434481257
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18512,514,0.77 [0.58-1.02],0.0647819340071794
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,44315,89,2.03 [1.17-3.54],0.0121193587578756
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16821,226,1.29 [0.86-1.95],0.2187508645335695
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,44308,4361,1.59 [1.46-1.74],2.7749842858647544e-25
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",40149,202,2.24 [1.68-2.99],4.093868388015551e-08
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40680,202,1.86 [1.26-2.75],0.0016913319428737
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,43693,94,1.06 [0.56-2.01],0.8478985521898297
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,39431,382,1.23 [0.90-1.68],0.199009602248134
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,44273,674,1.19 [0.94-1.51],0.1414971435559875
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18117,119,0.83 [0.47-1.47],0.5228718317098697
